Stocksigma LogoStocksigma Logo

Smruthi Organics Reports Strong Q1FY27 Results, Discontinues Formulations Division

Smruthi Organics reported strong Q1FY27 results, with Net Profit reaching Rs 287.81 lakh, a significant turnaround from a Rs 109.54 lakh loss YoY and up

Smruthi Organics Reports Strong Q1FY27 Results, Discontinues Formulations Division

Smruthi Organics Ltd 路 Outcome 路 10 Aug 2026, 5:54 pm

Smruthi Organics Reports Strong Q1FY27 Results, Discontinues Formulations Division Smruthi Organics reported strong Q1FY27 results, with Net Profit reaching Rs 287.81 lakh, a significant turnaround from a Rs 109.54 lakh loss YoY and up 169.7% QoQ. Revenue from operations grew 55.4% YoY to Rs 2,930.22 lakh. The Board approved the discontinuance of the Formulations Marketing Division on 13 May'26, which is now classified as a discontinued operation. The core Bulk Drugs and Intermediates (API) division is now the sole operating segment. Basic EPS from continuing operations stood at Rs 2.57 versus Rs (0.91) YoY.

Original exchange filing (PDF)

More announcements from Smruthi Organics Ltd

All Smruthi Organics Ltd announcements